Contact Us

Generic Products

In addition to our main activity in Combination products development, Pharma Two B utilizes its expertise in formulations and drug delivery systems to the development of selected complex generics products.

  • Pharma Two B develops non-infringing formulations and complete R&D files, including formulations, analytical methods, stability and pilot studies when applicable, of five generic products in various indications. 
  • Our development candidates are selected based on Market needs, competitions considerations and our in-house capabilities
  • R&D is planned and performed using Pharma Two B’s expertise in formulations, Drug Delivery Systems and API sourcing.
  •  

The company strategy is licensing the products for development and commercialization under milestone and royalty payments.

Since its establishment in December 2007, the company completed the development of 5 generic products, all of which were licensed to a US based partner, for further development, registration and commercialization in North America.

The company is open to licensing of the products in other global regions. 

R&D programs for generic products

 

Product Indication
P2B 005 Hyperphosphataemia
P2B 006  Hyperphosphataemia
P2B 007  Hyperlipidemia
P2B 008  Secondary hyperparathyroidism
P2B 009  Dry Eye